WHB-42119-68016
2 vaccinations
1 coded response
11 check-ins
1 free-text entry
0 call cases
- Sex
- Female
- Age at first dose
- 26-30
- ZIP prefix
- 537 / WI
- Registered
- 2022-03-30
- Relationship
- Adult relative or friend
- Guardian
- XV7-12905-44338
- Race
- Asian
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-04-01
Dose 1 — Janssen/Johnson & Johnson
-
2022-03-25
Dose 2 — Moderna
-
2022-03-30
Registered in v-safe
- 2022-03-30
-
2022-03-31
Health check-in — days 1–6 daily, dose 2, dependentFeeling: Fair · Nausea, Vomiting · Be unable to do your normal daily activitiesAdult check-in
- 2022-04-03
- 2022-04-08
- 2022-04-15
- 2022-04-22
- 2022-04-29
- 2022-05-06
-
2022-06-24
Survey response — 3 months, dose 2, dependentMedDRA: Cough, Nasopharyngitis — Feeling: Good · Be unable to do your normal daily activitiesFree text: Cold CoughMedDRA releases: 2024-11 · check-in free text available
- 2022-09-23
- 2023-03-25
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-04-01 | Janssen/Johnson & Johnson | No |
| 2 | 2022-03-25 | Moderna | No |
Free text
Release 12 — 3 months, dose 2, dependent
Symptoms: Cold Cough
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Cough | · | · | ✓ |
| SD | Nasopharyngitis | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release